<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 15 )*
---------
Abbott Laboratories
- -----------------------------------------------------------------------------
(Name of Issuer)
Common shares without par value
- -----------------------------------------------------------------------------
(Title of Class of Securities)
002824-10-0
------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /.
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
(Continued on following page (s))
Page 1 of 7 pages
<PAGE>
CUSIP No. 002824-10-0 13G Page 2 of 7 pages
- -----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Abbott Laboratories Stock Retirement Trust
I.R.S. Identification No. 36-6047554
- -----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
- -----------------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
- -----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH 64,148,697
REPORTING --------------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------
8 SHARED DISPOSITIVE POWER
64,148,697
- -----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
64,148,697
- -----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
/x/
- -----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.8%
- -----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
EP
- -----------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824-10-0 13G Page 3 of 7 pages
- -----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Gary P. Coughlan
###-##-####
- -----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
- -----------------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -----------------------------------------------------------------------------
5 SOLE VOTING POWER
(Does not include shares held in Abbott
74,916 shares - Laboratories Stock Retirement Trust for the
direct benefit of the reporting person.)
--------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES 64,148,697 - as Trustee, Abbott Laboratories Stock
BENEFICIALLY shares Retirement Trust
OWNED BY 1,085,640 - as Director, Abbott Laboratories Fund.
EACH --------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 74,916 shares (See note in 5 above)
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
64,148,697 as Trustee, Abbott Laboratories Stock
shares Retirement Trust.
1,085,640 as Director, Abbott Laboratories Fund.
- -----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
65,392,809 (Total of 5 + 6 + 83,556 shares - right to acquire by exercise
of stock options)
- -----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- -----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.0%
- -----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -----------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824-10-0 13G Page 4 of 7 pages
- -----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas C. Freyman
###-##-####
- -----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
- -----------------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -----------------------------------------------------------------------------
5 SOLE VOTING POWER
(Does not include shares held in Abbott
20,805 shares - Laboratories Stock Retirement Trust for the
direct benefit of the reporting person.)
--------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES as Trustee, Abbott Laboratories Stock
BENEFICIALLY 64,148,697 - Retirement Trust
OWNED BY
EACH --------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 20,805 shares (See note in 5 above)
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
64,148,697 as Trustee, Abbott Laboratories Stock
shares Retirement Trust.
- -----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
64,185,368 (Total of 5 + 6 + 15,866 shares - right to acquire by exercise
of stock options)
- -----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- -----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.8%
- -----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -----------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824-10-0 13G Page 5 of 7 pages
- -----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ellen M. Walvoord
###-##-####
- -----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
- -----------------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -----------------------------------------------------------------------------
5 SOLE VOTING POWER
(Does not include shares held in Abbott
19,000 shares - Laboratories Stock Retirement Trust for the
direct benefit of the reporting person.)
--------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES 64,148,697 - as Trustee, Abbott Laboratories Stock
BENEFICIALLY shares Retirement Trust
OWNED BY --------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 19,000 shares (See note in 5 above)
WITH
REPORTING --------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 64,148,697 - as Trustee, Abbott Laboratories Stock
shares Retirement Trust.
- -----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
64,192,033 (Total of 5 + 6 + 24,336 shares - right to acquire by exercise
of stock options)
- -----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- -----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.8%
- -----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -----------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
Abbott Laboratories
Item 1(b) Address of Issuers's Principal Executive Offices:
One Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(a) Name of Persons Filing:
Abbott Laboratories Stock Retirement Trust
Gary P. Coughlan
Thomas C. Freyman
Ellen M. Walvoord
Item 2(b) Address of Principal Business Office:
One Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(c) Citizenship:
Abbott Laboratories Stock Retirement Trust - Illinois.
Gary P. Coughlan, Thomas C. Freyman, and
Ellen M. Walvoord - United States
Item 2(d) Title of Class of Securities:
Common shares without par value
Item 2(e) CUSIP Number:
002824 10 0
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or
13d-2(b), check whether the person filing is an:
[X] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974.
Item 4. Ownership
(a) (See cover pages 2, 3,
(b) 4 and 5, Items 5 through
(c) 9 and 11.)
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Page 6 of 7 pages
<PAGE>
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
The shares owned by the Abbott Laboratories Stock Retirement Trust and
the dividends thereon are held for the benefit of participants of the
Abbott Laboratories Stock Retirement Plan pursuant to terms of that
Plan and the Trust. The Abbott Laboratories Stock Retirement Plan is
a qualified profit sharing plan. As of December 31, 1993, there were
35,148 participants with share balances in the Plan.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct. This statement is filed on behalf of each individual listed below
pursuant to their agreement.
February 11, 1994
------------------------------
Date
/s/ Gary P. Coughlan
- ------------------------------ ABBOTT LABORATORIES STOCK
Gary P. Coughlan RETIREMENT TRUST
/s/ Thomas C. Freyman
- ------------------------------
Thomas C. Freyman
/s/ Ellen M. Walvoord /s/ Thomas C. Freyman
- ------------------------------ ------------------------------
Ellen M. Walvoord Thomas C. Freyman, Chairman of
Trustees, Abbott Laboratories
Stock Retirement Trust
Page 7 of 7 pages
<PAGE>
DISCLAIMER OF BENEFICIAL OWNERSHIP
UNDER RULE 13d-4
The filing of Schedule 13G Amendment 15 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ Gary P. Coughlan
------------------------------
Gary P. Coughlan
February 11, 1994
------------------------------
Date
<PAGE>
DISCLAIMER OF BENEFICIAL OWNERSHIP
UNDER RULE 13d-4
The filing of Schedule 13G Amendment 15 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ Thomas C. Freyman
------------------------------
Thomas C. Freyman
February 11, 1994
------------------------------
Date
<PAGE>
DISCLAIMER OF BENEFICIAL OWNERSHIP
UNDER RULE 13d-4
The filing of Schedule 13G Amendment 15 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which she would not otherwise be deemed to be
beneficial owner.
/s/ Ellen M. Walvoord
------------------------------
Ellen M. Walvoord
February 11, 1994
------------------------------
Date
SEC/13G Form